Navigation Links
GMO Corn Causes Liver, Kidney Problems in Rats: Study

Environmental group Greenpeace launched a fresh attack on genetically modified maize developed by U.S. biotech giant Monsanto, saying on Tuesday that rats// fed on one version developed liver and kidney problems.

Greenpeace said a study it had commissioned that was published in the journal Archives of Environmental Contamination and Technology showed rats fed for 90 days on Monsanto's MON863 maize showed "signs of toxicity" in the liver and kidneys.

"It is the first time that independent research, published in a peer-reviewed journal, has proved that a GMO authorized for human consumption presents signs of toxicity," Arnaud Apoteker, a spokesman for Greenpeace France said in a statement.

Campaigners against Genetically Modified Organisms (GMO) say that genetic modification technology is unproven and potentially dangerous and that GMO crops can contaminate other crops.

The industry says the technology offers vast potential benefits, poses no health risk and has never been shown to contaminate other crops.

"All the experts agree that the maize in question is as safe as traditional maize," Yann Fichet, director external relations for Monsanto France told France's TF1 television.

He said the maize had been authorized in more than 10 countries and in the European Union but he declined to comment specifically on the allegations raised by Greenpeace.

MON863 is a form of maize genetically modified to make it resistant to corn rootworm. It has been authorized by the European Union for use in animal feed since 2005 and for human consumption since January 2006.

Source-Bio-Bio Technology
'"/>




Page: 1

Related medicine news :

1. Breast Cancer Surgery Causes Psychological problems
2. Causes of weakness in the aged
3. Gene Mutation Causes Ovarian Failure
4. Studying The Causes Of Autism
5. Heart Drug Also Effective In Preventing Specific Causes Of Death
6. More Causes of Bladder Cancer Identified
7. The Causes Of Acid Reflux Questioned
8. Causes of drug induced liver disease
9. Junk Food Causes High Level Of Insulin Resistance In Children
10. Red Color Causes The Allergic Reaction To Strawberries
11. Studies On Hearing Loss Discovers New Causes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: